Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
CytoDyn
Research
CytoDyn’s leronlimab reaffirms HIV potential with macaque study
CytoDyn's leronlimab may have struggled to secure approval as an HIV treatment, but research in infant primates has offered fresh hope.
Marissa Russo
Aug 12, 2026 4:30am
Ex-CytoDyn CEO sentenced as alleged co-conspirator wins new trial
Jan 26, 2026 11:00am
Judge rejects CytoDyn's motion to dismiss investor lawsuit
Jun 27, 2025 11:53am
Jury convicts 2 former biopharma leaders of fraud
Dec 11, 2024 10:26am
Amarex Clinical Research settles CytoDyn suit for $12M
Jul 9, 2024 3:40pm
CytoDyn finally clears FDA hold on HIV program after 2 years
Feb 29, 2024 10:20am
